Literature DB >> 30815455

Exercise Reduces Salivary Morning Cortisol Levels in Patients with Depression.

Md Shafiqur Rahman1, Xuan Zhao1, Jia Jia Liu2,3, Enid Quintana Torres1, Babylonia Tibert2,3, Parvin Kumar2,3, Viktor Kaldo4,5, Nils Lindefors4, Yvonne Forsell1, Catharina Lavebratt2,3.   

Abstract

PURPOSE OF THE STUDY: Cortisol hypersecretion plays a role in depression pathophysiology. Internet-based cognitive behavioural therapy (ICBT) and physical exercise (PE) are new treatment alternatives for depression, and their long-lasting effect on cortisol is unknown. We investigated cortisol level changes after 12 weeks of ICBT, PE or treatment as usual (TAU). PROCEDURES: The present pre-post repeated measure study analysed data derived from a randomised controlled trial evaluating the effects of 12 weeks' interventions of ICBT, PE and TAU in depressed primary care patients (Sweden 2011-2013) and aimed at prospectively evaluating the within-group effects of ICBT, PE and TAU on diurnal salivary cortisol levels in a small representative subsample (n = 56, 38 and 27, respectively).
RESULTS: We found a marked flattening of the diurnal cortisol slope (p = 0.004) and a reduced cortisol level at awakening (p = 0.017) after 12 weeks of PE treatment. No apparent effects of ICBT or TAU interventions were seen on diurnal cortisol levels. CONCLUSIONS AND MESSAGE: PE reduced the rate of cortisol level decline across the day in depressed adults. ICBT and TAU treatments had no detectable effects on diurnal cortisol levels. Larger samples are required for the detection and comparison of smaller effects of PE, ICBT and TAU on diurnal cortisol levels.

Entities:  

Keywords:  Hydrocortisone; Hypothalamus; Pituitary-adrenal system; Saliva

Year:  2018        PMID: 30815455      PMCID: PMC6388436          DOI: 10.1159/000494699

Source DB:  PubMed          Journal:  Mol Neuropsychiatry        ISSN: 2296-9179


  35 in total

1.  Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change.

Authors:  Jens C Pruessner; Clemens Kirschbaum; Gunther Meinlschmid; Dirk H Hellhammer
Journal:  Psychoneuroendocrinology       Date:  2003-10       Impact factor: 4.905

2.  Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs.

Authors:  Michael Gröschl; Henrik Köhler; Hans-Georg Topf; Thomas Rupprecht; Manfred Rauh
Journal:  J Pharm Biomed Anal       Date:  2008-02-05       Impact factor: 3.935

Review 3.  Central mechanisms of HPA axis regulation by voluntary exercise.

Authors:  Alexis M Stranahan; Kim Lee; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2008-02-14       Impact factor: 3.843

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

5.  The effect of depressive symptomatology on plasma cortisol responses to acute bicycle exercise among post-menopausal women.

Authors:  G van der Pompe; N Bernards; T F Meijman; C J Heijnen
Journal:  Psychiatry Res       Date:  1999-01-18       Impact factor: 3.222

6.  Stability of salivary steroids: the influences of storage, food and dental care.

Authors:  M Gröschl; R Wagner; M Rauh; H G Dörr
Journal:  Steroids       Date:  2001-10       Impact factor: 2.668

7.  Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms.

Authors:  Chanudda Nabkasorn; Nobuyuki Miyai; Anek Sootmongkol; Suwanna Junprasert; Hiroichi Yamamoto; Mikio Arita; Kazuhisa Miyashita
Journal:  Eur J Public Health       Date:  2005-08-26       Impact factor: 3.367

8.  Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.

Authors:  Maurizio Fava; W Vaughn McCall; Andrew Krystal; Thomas Wessel; Robert Rubens; Judy Caron; David Amato; Thomas Roth
Journal:  Biol Psychiatry       Date:  2006-04-03       Impact factor: 13.382

9.  Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia.

Authors:  Rachel Manber; Jack D Edinger; Jenna L Gress; Melanie G San Pedro-Salcedo; Tracy F Kuo; Tasha Kalista
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

10.  Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients.

Authors:  Evelyn Kiive; Jaak Maaroos; Jakov Shlik; Innar Tõru; Jaanus Harro
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-09       Impact factor: 5.067

View more
  2 in total

1.  Aerobic Exercise and Stretching as Add-On to Inpatient Treatment for Depression Have No Differential Effects on Stress-Axis Activity, Serum-BDNF, TNF-Alpha and Objective Sleep Measures.

Authors:  Christian Imboden; Markus Gerber; Johannes Beck; Anne Eckert; Imane Lejri; Uwe Pühse; Edith Holsboer-Trachsler; Martin Hatzinger
Journal:  Brain Sci       Date:  2021-03-24

Review 2.  The Effects of Physical Exercise on Saliva Composition: A Comprehensive Review.

Authors:  Panagiotis Ntovas; Nikolaos Loumprinis; Panagiotis Maniatakos; Loukia Margaritidi; Christos Rahiotis
Journal:  Dent J (Basel)       Date:  2022-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.